Literature DB >> 11381124

Ullrich scleroatonic muscular dystrophy is caused by recessive mutations in collagen type VI.

O Camacho Vanegas1, E Bertini, R Z Zhang, S Petrini, C Minosse, P Sabatelli, B Giusti, M L Chu, G Pepe.   

Abstract

Ullrich syndrome is a recessive congenital muscular dystrophy affecting connective tissue and muscle. The molecular basis is unknown. Reverse transcription-PCR amplification performed on RNA extracted from fibroblasts or muscle of three Ullrich patients followed by heteroduplex analysis displayed heteroduplexes in one of the three genes coding for collagen type VI (COL6). In patient A, we detected a homozygous insertion of a C leading to a premature termination codon in the triple-helical domain of COL6A2 mRNA. Both healthy consanguineous parents were carriers. In patient B, we found a deletion of 28 nucleotides because of an A --> G substitution at nucleotide -2 of intron 17 causing the activation of a cryptic acceptor site inside exon 18. The second mutation was an exon skipping because of a G --> A substitution at nucleotide -1 of intron 23. Both mutations are present in an affected brother. The first mutation is also present in the healthy mother, whereas the second mutation is carried by their healthy father. In patient C, we found only one mutation so far-the same deletion of 28 nucleotides found in patient B. In this case, it was a de novo mutation, as it is absent in her parents. mRNA and protein analysis of patient B showed very low amounts of COL6A2 mRNA and of COL6. A near total absence of COL6 was demonstrated by immunofluorescence in fibroblasts and muscle. Our results demonstrate that Ullrich syndrome is caused by recessive mutations leading to a severe reduction of COL6.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11381124      PMCID: PMC34700          DOI: 10.1073/pnas.121027598

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  26 in total

1.  A novel de novo mutation in the triple helix of the COL6A3 gene in a two-generation Italian family affected by Bethlem myopathy. A diagnostic approach in the mutations' screening of type VI collagen.

Authors:  G Pepe; E Bertini; B Giusti; T Brunelli; P Comeglio; B Saitta; L Merlini; M L Chu; G Federici; R Abbate
Journal:  Neuromuscul Disord       Date:  1999-06       Impact factor: 4.296

2.  Bethlem myopathy and engineered collagen VI triple helical deletions prevent intracellular multimer assembly and protein secretion.

Authors:  S R Lamandé; K A Shields; A J Kornberg; L K Shield; J F Bateman
Journal:  J Biol Chem       Date:  1999-07-30       Impact factor: 5.157

3.  Reduced collagen VI causes Bethlem myopathy: a heterozygous COL6A1 nonsense mutation results in mRNA decay and functional haploinsufficiency.

Authors:  S R Lamandé; J F Bateman; W Hutchison; R J McKinlay Gardner; S P Bower; E Byrne; H H Dahl
Journal:  Hum Mol Genet       Date:  1998-06       Impact factor: 6.150

4.  Respiratory muscle involvement in Bethlem myopathy.

Authors:  R U Haq; M C Speer; M L Chu; R Tandan
Journal:  Neurology       Date:  1999-01-01       Impact factor: 9.910

5.  Cytokine gene expression in human LPS- and IFNgamma-stimulated mononuclear cells is inhibited by heparin.

Authors:  M Attanasio; A M Gori; B Giusti; G Pepe; P Comeglio; T Brunelli; D Prisco; R Abbate; G F Gensini; G G Neri Serneri
Journal:  Thromb Haemost       Date:  1998-05       Impact factor: 5.249

6.  Bethlem myopathy: a slowly progressive congenital muscular dystrophy with contractures.

Authors:  G J Jöbsis; J M Boers; P G Barth; M de Visser
Journal:  Brain       Date:  1999-04       Impact factor: 13.501

7.  A clinical and histological study of Ullrich's disease (congenital atonic-sclerotic muscular dystrophy).

Authors:  I Nonaka; Y Une; T Ishihara; S Miyoshino; T Nakashima; H Sugita
Journal:  Neuropediatrics       Date:  1981-08       Impact factor: 1.947

8.  A heterozygous splice site mutation in COL6A1 leading to an in-frame deletion of the alpha1(VI) collagen chain in an italian family affected by bethlem myopathy.

Authors:  G Pepe; B Giusti; E Bertini; T Brunelli; B Saitta; P Comeglio; A Bolognese; L Merlini; G Federici; R Abbate; M L Chu
Journal:  Biochem Biophys Res Commun       Date:  1999-05-19       Impact factor: 3.575

9.  What is muscular dystrophy? Forty years of progressive ignorance.

Authors:  V Dubowitz
Journal:  J R Coll Physicians Lond       Date:  2000 Sep-Oct

10.  Benign myopathy, with autosomal dominant inheritance. A report on three pedigrees.

Authors:  J Bethlem; G K Wijngaarden
Journal:  Brain       Date:  1976-03       Impact factor: 13.501

View more
  72 in total

1.  Genomewide linkage and linkage disequilibrium analyses identify COL6A1, on chromosome 21, as the locus for ossification of the posterior longitudinal ligament of the spine.

Authors:  Toshihiro Tanaka; Katsunori Ikari; Kozo Furushima; Akihiro Okada; Hiroshi Tanaka; Ken-Ichi Furukawa; Kenichi Yoshida; Toshiyuki Ikeda; Shiro Ikegawa; Steven C Hunt; Jun Takeda; Satoshi Toh; Seiko Harata; Toshiaki Nakajima; Ituro Inoue
Journal:  Am J Hum Genet       Date:  2003-09-04       Impact factor: 11.025

Review 2.  Animal models of muscular dystrophy.

Authors:  Rainer Ng; Glen B Banks; John K Hall; Lindsey A Muir; Julian N Ramos; Jacqueline Wicki; Guy L Odom; Patryk Konieczny; Jane Seto; Joel R Chamberlain; Jeffrey S Chamberlain
Journal:  Prog Mol Biol Transl Sci       Date:  2012       Impact factor: 3.622

3.  Collagen VI microfibril formation is abolished by an {alpha}2(VI) von Willebrand factor type A domain mutation in a patient with Ullrich congenital muscular dystrophy.

Authors:  Leona D Tooley; Laura K Zamurs; Nicola Beecher; Naomi L Baker; Rachel A Peat; Naomi E Adams; John F Bateman; Kathryn N North; Clair Baldock; Shireen R Lamandé
Journal:  J Biol Chem       Date:  2010-08-21       Impact factor: 5.157

4.  Structure of a collagen VI α3 chain VWA domain array: adaptability and functional implications of myopathy causing mutations.

Authors:  Herimela Solomon-Degefa; Jan M Gebauer; Cy M Jeffries; Carolin D Freiburg; Patrick Meckelburg; Louise E Bird; Ulrich Baumann; Dmitri I Svergun; Raymond J Owens; Jörn M Werner; Elmar Behrmann; Mats Paulsson; Raimund Wagener
Journal:  J Biol Chem       Date:  2020-07-21       Impact factor: 5.157

Review 5.  The congenital muscular dystrophies: recent advances and molecular insights.

Authors:  Jerry R Mendell; Daniel R Boué; Paul T Martin
Journal:  Pediatr Dev Pathol       Date:  2006 Nov-Dec

6.  Large genomic deletions: a novel cause of Ullrich congenital muscular dystrophy.

Authors:  A Reghan Foley; Ying Hu; Yaqun Zou; Michele Yang; Līvija Medne; Meganne Leach; Laura K Conlin; Nancy Spinner; Tamim H Shaikh; Marni Falk; Ann M Neumeyer; Laurie Bliss; Brian S Tseng; Thomas L Winder; Carsten G Bönnemann
Journal:  Ann Neurol       Date:  2011-01       Impact factor: 10.422

Review 7.  The collagenopathies: review of clinical phenotypes and molecular correlations.

Authors:  Rebekah Jobling; Rohan D'Souza; Naomi Baker; Irene Lara-Corrales; Roberto Mendoza-Londono; Lucie Dupuis; Ravi Savarirayan; L Ala-Kokko; Peter Kannu
Journal:  Curr Rheumatol Rep       Date:  2014-01       Impact factor: 4.592

8.  A homozygous COL6A2 intron mutation causes in-frame triple-helical deletion and nonsense-mediated mRNA decay in a patient with Ullrich congenital muscular dystrophy.

Authors:  Laura Lucarini; Betti Giusti; Rui-Zhu Zhang; Te-Cheng Pan; Cecilia Jimenez-Mallebrera; Eugenio Mercuri; Francesco Muntoni; Guglielmina Pepe; Mon-Li Chu
Journal:  Hum Genet       Date:  2005-06-17       Impact factor: 4.132

Review 9.  Mitochondrial dysfunction and defective autophagy in the pathogenesis of collagen VI muscular dystrophies.

Authors:  Paolo Bernardi; Paolo Bonaldo
Journal:  Cold Spring Harb Perspect Biol       Date:  2013-05-01       Impact factor: 10.005

10.  New molecular mechanism for Ullrich congenital muscular dystrophy: a heterozygous in-frame deletion in the COL6A1 gene causes a severe phenotype.

Authors:  Te-Cheng Pan; Rui-Zhu Zhang; Dominick G Sudano; Suely K Marie; Carsten G Bönnemann; Mon-Li Chu
Journal:  Am J Hum Genet       Date:  2003-07-01       Impact factor: 11.025

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.